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Volume 54, Number 2 Abstracts 591.0001). On multivariate analysis, the strongest independent predictor for
transfer remained nonmetropolitan hospital (Table). The West had the
lowest likelihood of transfer compared to other regions and the highest
likelihood of ED death (odds ratio [OR], 1.91, 95% confidence interval
[CI], 1.19-3.08; P  .008).
Conclusions:Transfer is rarely used for treatment of rAAA. Higher ED
deaths at hospitals with lower likelihood of transfer suggest that better
transfer protocols may improve survival for patients who present to hospital
EDs with insufficient resources to provide local care.
Table. Predictors of transfer for rAAA
Factor
Adjusted
OR 95% CI P value
Non-metropolitan
hospital 24.4 9.6–62.5  .0001
Non-trauma hospital 10.0 4.9–20.7  .0001
Region
East 4.1 1.3–12.6 .0002
South 6.8 2.5–18.0 .0001
Midwest 6.4 2.4–17.2 .0003
West 1.0 NA Referent
Age (per decade) 0.72 0.58–0.88 .002
CI, Confidence interval; OR, odds ratio.
The Use of Sartorius Muscle Rotational Flaps for Groin Complications
after Vascular Reconstruction
Christian Ochoa, MD, Vahagn Nikolian, Sarah Wartman, MD, William Lee,
MD, Fred A. Weaver, MD, and Vincent Rowe, MD, Department of Vascular
Surgery, University of Southern California, Los Angeles, Calif.
Objectives: Sartorius myoplasty has been shown to be an adequate
adjunct for soft tissue coverage in vascular groin infections. However, in the
era of antibiotic resistant bacterial infections, the durability of the sartorius
myoplasty has been questioned. It is the purpose of this study to determine
whether sartorius myoplasty is a durable option for wound complications
after vascular reconstruction.
Methods: The medical records of all patients undergoing sartorius
myoplasty from 1997 to 2010 were reviewed. Failure of sartorius myoplasty
was defined as operative reintervention for bleeding, persistent wound
drainage, and infection. The 2 and Mann-Whitney U statistics were per-
formed, with a P  .05.
Results: A total of 69 patients underwent sartorius myoplasty during
the study period. Forty-two patients were female and 27 were male and the
average age was 68 years old. Fifty-four percent of the patients had previous
infrainguinal reconstruction. Presenting symptoms included fever in 19%,
sepsis in 8%, pseudoaneurysm in 15%, acute leg ischemia in 22%, and
presence of a foot wound in 25%. Fifty-nine percent of the patients presented
with wound drainage. Intraoperative wound cultures consisted of methicil-
lin sensitive Staphylococcus (39%), methicillin-resistant Staphylococcus (34%),
Enterococcus (35%), Pseudomonas aeruginosa (13%), E. Coli (15%), and
polymicrobial (32%). The failure rate for sartorius myoplasty was 10.1%. For
those patients who failed, a total of 4 had persistent bleeding, 2 patients had
recurrent wound infections requiring redebridement and 1 patient had
necrotizing fasciitis. Univariate analysis found that admission white blood
cell (WBC) count to be a significant factor in those patients who failed
sartorius myoplasty (failed-WBC 18 vs nonfailure WBC 10.2; P  .027).
The presence of wound drainage and microbacteria did not have a significant
effect on the failure of sartorius myoplasty.
Conclusions: In the current setting, sartorius myoplasty provides
reliable soft tissue coverage for vascular groin infections.
Accreditation Council for Continuing Medical Education (ACCME):
The data presented in this abstract demonstrates that in patients with groin
infections, the placement of a muscle flap can impact wound healing and
prove to be a durable method. The treatment gap in this setting is between
wound vac placement vs muscle flap coverage.
No Increased Mortality with Early Aortic Aneurysm Disease
Matthew Mell, MD, Julie J. White, BS, Bradley B. Hill, MD, and Ronald L.
Dalman, MD, Department of Surgery, Stanford University, Stanford, Calif.
Objective: In addition to increased risks for aneurysm-related death,
previous studies have determined that all-cause mortality in patients with
abdominal aortic aneurysms was excessive and equivalent to that associated
with coronary heart disease (CHD). These studies largely preceded the
current era of CHD risk factor management, however, no recent study has
examined contemporary mortality associated with early AAA disease (aneu-
V
lysm diameter between 3 and 5 cm). As part of an ongoing natural history
tudy of AAAs, we report the mortality risk associated with the presence of
arly disease.
Methods: Participants were recruited from three distinct health care
ystems in Northern California between 2006 and 2011. Aneurysm diame-
er, demographic information, comorbidities, medication history, and
lasma for biomarker analysis were collected at study entry. Survival status
as determined at follow-up. Data were analyzed with t test or 2 test where
ppropriate. Freedom from death was calculated via Cox proportional
azards modeling; the relevance of individual predictors on mortality was
etermined by log-rank test.
Results: The study enrolled 645 patients with AAAs; aged 76.5 
.0 years old, and aortic diameter 3.9  0.7 cm. Participants were mostly
en (88.8%), nonsmokers (81.8%), and taking statins (76.7%). Mean
ollow-up was 2.1 1.0 years. Estimated 1-year and 3-year mortality was
nly 1.7 and 5.3%, respectively. Factors independently associated with
ortality included larger aneurysm size (hazard ratio [HR], 2.67; 95%
onfidence interval [CI], 1.26-5.70 for diameter 4.0 cm), and diabetes
HR 2.75; 95% CI, 1.30-5.82). After adjusting for patient-level factors,
he health care system independently predicted mortality: institution 2 vs
(HR, 2.34; 95% CI, .93-5.90); institution 3 vs 1 (HR, 2.61; 95% CI,
.13-6.06).
Conclusions: Contemporary all-cause mortality for patients with early
AA disease is lower than that previously reported, and currently approxi-
ates adjusted mortality for the population at large. Despite this overall
mprovement, however, mortality rates for similar patients vary between
ifferent health care systems within the same region. Further research is
arranted to determine institutional factors that contribute to disparate
urvival in early AAA disease.
orrelation of CEAP Clinical Class, Venous Clinical Severity Scores,
ein Diameter, and Reflux Time in the Great Saphenous Vein in
atients with Superficial Venous Insufficiency
atthew M. Wise, BS, RVT, and Kathleen D. Gibson, MD, Lake Washing-
on Vascular Surgeons and Vascular Laboratories, Bellevue, Wash.
Objective: With the advent of minimally invasive techniques to treat
uperficial venous insufficiency, the volume of varicose vein procedures
erformed in the United States has increased substantially. Insurers are
tarting to utilize specific duplex-derived measures (specifically great
aphenous vein [GSV] diameter and reflux time) to approve or deny
overage of these procedures. The purpose of this study was to assess the
elationship between physician-derived CEAP clinical class, venous clin-
cal severity score (VCSS), and quantitative data obtained from duplex
ltrasound scan.
Methods: A retrospective analysis was performed on all patients
ho underwent a duplex ultrasound scan for venous reflux/venous stasis
isease over a 7-month period (n  739) at a single outpatient vascular
aboratory. For the purposes of this study, we included only those
atients with documented saphenofemoral junction reflux. Patients with
xtensive deep vein reflux, deep vein thrombosis, and superficial throm-
ophlebitis were also excluded. Three hundred seventy patients met this
riteria, and all had diameter and reflux times measured at the saphe-
ofemoral junction/proximal thigh. Two hundred thirty-nine of the 370
atients had documented CEAP and VCSS scores. Pearson correlation
oefficients were used to assess the correlation between GSV diameter,
eflux time, CEAP class, and VCSS.
Results: The average patient age was 51 and 81% were female. VCSS
cores ranged from 2 to 15 and CEAP ranged between 2 and 6. Mean
eflux time was 5.9 seconds (0.9-12) and the GSV diameter mean was 7.7
m (2.6-19). Statistical analysis showed there was no significant rela-
ionship between reflux time and vein diameter (r  .148). A moderate
orrelation existed between vein diameter and both CEAP and VCSS
cores (r .382 and 0.419, respectively; P .01). No correlation existed
etween reflux time and CEAP/VCSS scores (r  .103 and 0.082,
espectively).
Conclusions: In our population, there was no relationship between
eflux time and CEAP/VCSS scores, and only a moderate relationship
etween GSV diameter and these physician-derived scores. Using GSV
iameter and/or reflux times alone as surrogate markers for disease
everity may be inappropriate. This abstract addresses the relationship
etween ultrasound scan findings and CEAP/VCSS scores. Patient out-
ome can improve if we fully understand the criteria used to measure
isease severity.
lack Patients Are Less Likely to Receive First Time Arteriovenous
istulas: A Question of Smaller Vein Diameters
randon Ishaque, Mohamed A. Zayed, MD, PhD, Jessica Miller, Amy H.
aji, MD, PhD, Jason T. Lee, MD, Jessica O’Connell, MD, and Christian de
irgilio, MD, Department of Surgery, University of California – Los Ange-
es, Los Angeles, Calif.
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August 2011592 AbstractsObjective: The National Kidney Foundation has recommended
utilizing autogenous arteriovenous fistulas (AVFs) in at least 50% of all
new patients with endstage renal disease (ESRD). Some studies suggest
that black patients are less likely to receive first time AVF than other
ethnicities, although the reason for this disparity is unclear. The purpose
of our study was to determine whether racial differences influence AVF
preference over grafts and whether this may be related to differences in
vein diameters.
Methods: Consecutive patients undergoing first-time hemodialysis
access from 2006 to 2010 at two institutions were retrospectively re-
viewed. Data collected included age, gender, ethnicity, weight, height,
body surface area (BSA), diabetes, hypertension, congestive heart failure,
smoking history, intravenous drug abuse, need for temporary access
placement, and preoperative venous ultrasound scan measurements.
Categorical variables were compared using 2 and odds ratios, whereas
the Wilcoxon-rank sum test was used to compare continuous variables.
Results: Two hundred eighty patients (99 black) were identified for
the study. Median age in black and nonblack patients was 63 years old. All
patients underwent preoperative duplex scan, and black patients demon-
strated statistically significant, smaller median basilic and cephalic vein
diameters at all measured sites except at the cephalic vein distal forearm
and proximal upper arm. Overall, 249 patients (90%) underwent AVF
first. Arteriovenous (AV) graft was created in 18% of black patients vs
only 7% of nonblacks (odds ratio [OR], 2.9; 95% confidence interval
[CI], 1.3-6.1; P .0005). Weight and BSA were statistically significantly
different between black and nonblack patients, whereas the need for
temporary access before hemoaccess was similar between the cohorts.
After adjusting for weight and BSA, black patients were still more likely
to undergo AV graft (OR, 2.9; 95% CI, 1.3-6.6; P  .007).
Conclusions: Black patients are less likely to undergo AVF during first
time hemodialysis access surgery, likely due to their smaller preoperative
measurements in basilic and cephalic vein diameters.
Duplex Ultrasound Criteria for Re-intervention after Mesenteric Ar-
tery Revascularization
Aaron C. Baker, Victoria Chew, Chin-Shang Li, PhD, Tzu-Chun Lin, David
L. Dawson, MD, William C. Pevec, MD, and Nasim Hedayati, MD,
Department of General Surgery, University of California Davis Health
System, Sacramento, Calif.
Objective: Currently, there are no well established duplex ultrasound
(DUS) scan criteria for the evaluation of the superior mesenteric artery
(SMA) after stenting for occlusive disease. Previous studies suggested DUS
velocity criteria in native SMA overestimate stenosis in stented arteries, but
no study has evaluated DUS after SMA stenting longitudinally. This study
was undertaken to determine the accuracy of DUS in evaluation of SMA
in-stent restenosis.
Methods: We identified all patients who underwent SMA/celiac artery
stenting and mesenteric bypass grafting from January 2004 to December
2010.
Results: Twenty-seven patients with symptomatic mesenteric ischemia
were treated with mesenteric stenting and 15 patients with mesenteric
bypass grafting. Eighteen pre-stent DUS showed SMA peak systolic velocity
(PSV) of 471  118 cm/second. Pre-stenting angiography revealed SMA
stenosis of 72  15%. Completion angiography revealed 15% residual
stenosis. No significant correlation was identified between SMA PSV and
angiographic stenosis pre-stenting and post-stenting. Follow-up SMA DUS
showed a PSV of 365  130 cm/seconds at 2  5 months, PSV of 377 
145 cm/seconds at 5 3 months, and a PSV of 375 103 cm/seconds at
15 4 months. A significant difference existed between pre-stenting and the
first post-stenting SMA PSV (P value  .05), but no significant difference
existed between each post-stenting interval. Six patients (5 asymptomatic, 1
symptomatic) had repeat mesenteric angiography for elevated SMA stent
PSV of 490  87 cm/seconds (vs 343  146 cm/seconds in patients who
did not undergo reintervention). Angiography demonstrated 57%  13
stenosis of the SMA. Four patients underwent re-stenting and 1 patient had
angioplasty. PSV decreased to 380 57 cm/seconds postprocedure. In the
patients who had SMA bypass grafting, DUS did not show a change in PSV
over time.
Conclusion: As has been previously shown in DUS studies of carotid
and renal artery stents, our data demonstrate that PSV in successfully stented
SMAs is higher than the PSV of 275 cm/seconds used for diagnosing
stenosis of non-stented SMAs. More importantly, PSV of stented SMAs do
not significantly change over time. DUS should be considered early after
mesenteric intervention to identify significant residual stenosis that may
need early reintervention and to provide a baseline for future follow-up.
Durability and Stroke-Free Survival after Carotid Stenting: Long-
Term Follow-up in a Community Setting
Peter A. Schneider, MD, Michael Peterson, MD, Michael T. Caps, MD, and
Nicolas Nelken, MD, Department of Vascular Therapy, Hawaii Permanente
Medical Group, Honolulu, Hawaii. VObjectives: The purpose of carotid angioplasty and stent (CAS) is
troke prevention. Large trials have been conducted or are underway to
nderstand the results of CAS. However, two significant questions remain:
1) What are the long-term results, beyond the reports of 2 to 4 years? (2)
o the results of major trials correlate with similar results in the community
t large? The purpose of this study is twofold: to evaluate the long-term
esults of CAS with respect to stroke-free survival, re-stenosis, and reinter-
ention; and, to assess the overall result of CAS in a community setting.
Methods:Over a 9-year period (2002-2010), we used CAS as a treatment
or significant carotid stenosis in 162 procedures in 150 patients. In most of the
atients, there was one or more anatomic or physiological indication for CAS
ue to high-risk status for carotid endarterectomy. After CAS, patients were
ollowed with surveillance duplex scan in a certified vascular laboratory at 1
onth, 6 months, 1 year, and annually thereafter. Peak systolic velocity (PSV)
200 cm/seconds was considered to be a re-stenosis of50% and PSV300
m/seconds was considered to be70% re-stenosis. Repeat interventions were
erformed at the discretion of the treating surgeon.
Results: The risk of perioperative stroke was 3.1% and death was 0.6%.
ean follow-up was 2.6 years with a range of 0 to 8.9 years. One hundred
wenty of the procedures (74%) had a follow-up of at least 1 year. Stroke-free
urvival at 1, 3, and 5 years was 91%, 70%, and 53%, respectively. Freedom from
ll causes of stroke was 96% at 1 year, 95% at 3 years, and 92% at 5 years.
e-stenosis of 50% or more occurred in 4% at 1 year, 8% at 3 years, and 8% at 5
ears. Re-stenosis of 70% or more occurred in 2% at 1 year, 6% at 3 years, and 6%
t 5 years. Only three (1.9%) of the index procedures required re-treatment.
one of the patients with recurrent stenosis presented with neurologic symp-
oms. None of the patients died of stroke during long-term follow-up.
Conclusion: Long-term stroke-free survival was diminished in this
opulation at high risk for carotid surgery. The rates of re-stenosis, reinter-
ention, and stroke from any cause were acceptable after CAS. These data
uggest that CAS can be performed in a community setting with acceptable
ong-term durability and stroke prevention.
erioperative Complications Associated with Femoral Vein Harvest
avi V. Dhanisetty, Timothy K. Liem, MD, Gregory L. Landry, MD, Erica
. Mitchell, MD, and Gregory L. Moneta, MD, Department of Surgery,
regon Health & Science University, Portland, Ore.
Objectives: The femoral vein is increasingly used as a conduit in
ajor arterial and venous reconstructions. However, the perioperative
omplications associated with femoral vein harvest (FVH) are not well
escribed. The purpose of this study was to determine the incidence and
isk factors for the development of deep venous thrombosis in patients
ho undergo FVH.
Methods: All patients who underwent FVH over a 5-year period were
eviewed. Patient clinical characteristics and indications for surgery were
etermined from an electronic medical record query. Postoperative venous
uplex scans and computerized tomography scans of the chest were re-
iewed. Data were analyzed using t test.
Results: Fifty-seven patients (53% male, mean age 62 years old)
nderwent 58 FVH procedures. Fifty-three percent of procedures were
erformed for arterial reconstruction and 47% for major venous recon-
truction after cancer resection (80% portomesenteric reconstruction).
erioperative ipsilateral deep venous thrombosis (DVT) was detected in
7 of 58 FVH procedures (29%). Eleven (19%) were isolated to the veins
istal to the FVH site, and 6 (10%) occurred proximal to the FVH site.
he incidence of DVT was significantly greater in patients with malig-
ancy (56% vs 13%; P value  .003). All DVTs proximal to the vein
arvest site occurred in patients with malignancy. Pulmonary embolism
ccurred in 2 patients, and none of the patients developed compartment
yndrome or limb loss. Eight patients (14%) required bedside or opera-
ive FVH wound debridement.
Conclusions: FVH is frequently associated with ipsilateral DVT, and the
ncidence is significantly higher in patients with malignancy. Aggressive throm-
oprophylaxis may be warranted after femoral vein harvest, especially in patients
ith known malignancy. Longer-term studies are needed to determine the
atural history of DVTs associated with femoral vein harvest.
evelopment of a Rapid, High Resolution Magnetic Resonance Imag-
ng Protocol for the Assessment of Arteriovenous Fistula Remodeling
arren J. Gasper,a Monica Sigovan,b Vitalliy Rayz,b Joseph Rapp,a David
aloner,b Christopher D. Owens,a aVascular Surgery and bRadiology, Uni-
ersity of California San Francisco, San Francisco, Calif.
Objective: To investigate the relationship of hemodynamic forces to
tructural remodeling in the maturing arteriovenous fistula (AVF), we
eveloped a rapid MRI-based AVF imaging protocol from a series of newly
reated and mature AVFs. In addition, we report, for the first time, use of a
on-gadolinium-based contrast agent, ferumoxytol, for contrast-enhanced
RA (CE-MRA) of an AVF.Methods: This was a cross-sectional study of subjects with stage IV or
chronic kidney disease before and after AVF creation. The imaging
